Stonebrook Private Inc. raised its position in The Allstate Co. (NYSE:ALL – Free Report) by 6.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,066 shares of the insurance provider’s stock after acquiring an additional 231 shares during the quarter. Stonebrook Private Inc.’s holdings in Allstate were worth $771,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the company. Pathway Financial Advisers LLC grew its position in shares of Allstate by 18,472.5% during the third quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after buying an additional 1,047,019 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Allstate by 18.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock worth $569,114,000 after purchasing an additional 472,040 shares during the last quarter. AQR Capital Management LLC lifted its stake in Allstate by 181.6% during the second quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider’s stock worth $114,955,000 after purchasing an additional 464,337 shares during the last quarter. TimesSquare Capital Management LLC bought a new position in Allstate during the third quarter worth $77,819,000. Finally, Acadian Asset Management LLC lifted its stake in Allstate by 3,839.0% during the second quarter. Acadian Asset Management LLC now owns 416,117 shares of the insurance provider’s stock worth $66,417,000 after purchasing an additional 405,553 shares during the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.
Wall Street Analyst Weigh In
ALL has been the topic of several research analyst reports. Morgan Stanley raised their price objective on Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a research note on Thursday, November 7th. The Goldman Sachs Group raised their price objective on Allstate from $209.00 to $230.00 and gave the stock a “buy” rating in a research note on Friday, November 15th. JPMorgan Chase & Co. boosted their price target on shares of Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a report on Thursday, October 10th. Wells Fargo & Company boosted their price target on shares of Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a report on Tuesday, November 5th. Finally, Roth Mkm reissued a “buy” rating and set a $200.00 price target on shares of Allstate in a report on Wednesday, August 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Allstate currently has an average rating of “Moderate Buy” and a consensus price target of $214.19.
Insiders Place Their Bets
In other news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. This represents a 57.06 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.80% of the company’s stock.
Allstate Price Performance
Shares of NYSE ALL opened at $203.80 on Friday. The Allstate Co. has a twelve month low of $134.17 and a twelve month high of $205.35. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The company has a market capitalization of $53.97 billion, a price-to-earnings ratio of 13.20, a PEG ratio of 1.75 and a beta of 0.48. The firm has a 50-day moving average of $191.41 and a two-hundred day moving average of $177.77.
Allstate (NYSE:ALL – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. The company had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. Allstate’s revenue was up 14.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.81 EPS. As a group, analysts expect that The Allstate Co. will post 16.01 earnings per share for the current fiscal year.
Allstate Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.81%. Allstate’s payout ratio is presently 23.83%.
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
- Five stocks we like better than Allstate
- 3 Monster Growth Stocks to Buy Now
- MarketBeat Week in Review – 11/18 – 11/22
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
- NYSE Stocks Give Investors a Variety of Quality Options
- Tesla Investors Continue to Profit From the Trump Trade
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.